![]() Comet Therapeutics Comet Therapeutics focuses on the development of a portfolio of drug candidates that centers around efforts to re-engineer CoEnzyme-A (CoA). | ChemICare ChemICare is a company that specializes in orphan drugs for patients affected by calcium-related genetic diseases. | ||
Founding Date | Founding Date 2020 | Founding Date 2018 | Founding Date 2016 |
Type | Type Private | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ Woburn, US | Locations HQ | Locations Novara, IT HQ Novara, IT |
Employees | Employees 761% decrease | Employees 1 | Employees N/A |
Funding | |||
Latest funding round | Latest funding round $ 115m (over 4 years ago) | Latest funding round N/A | Latest funding round $ 81.7k (over 7 years ago) |
Total funding raised | Total funding raised $ 135m | Total funding raised $ 28.5m | Total funding raised $ 81.7k |

Comet Therapeutics focuses on the development of a portfolio of drug candidates that centers around efforts to re-engineer CoEnzyme-A (CoA).
View companyChemICare is a company that specializes in orphan drugs for patients affected by calcium-related genetic diseases.
View company